Cutaneous manifestations in costello and cardiofaciocutaneous syndrome: Rport of 18 cases and literature review

Pediatric Dermatology

Volumn 30, Issue 6, 2013, Pages 665-673

  Morice Picard, Fanny ^a,b   Ezzedine, Khaled ^a   Delrue, Marie Ange ^b   Arveiler, Benoit ^b   Fergelot, Patricia ^b   Taïeb, Alain ^a   Lacombe, Didier ^b   Boralevi, Franck ^a  

^a Paediatric Dermatology Unit   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; CARDIOFACIOCUTANEOUS SYNDROME; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COSTELLO SYNDROME; CUTIS LAXA; FEMALE; HUMAN; HYPERHIDROSIS; INFANT; MALE; OBSERVATIONAL STUDY; PAPILLOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; REVIEW; SCHOOL CHILD; SKIN EXAMINATION; SKIN MANIFESTATION; SYNDROME; WORKSHOP;

CHILD; CHILD, PRESCHOOL; COSTELLO SYNDROME; DIAGNOSIS, DIFFERENTIAL; ECTODERMAL DYSPLASIA; FACIES; FAILURE TO THRIVE; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; MAP KINASE SIGNALING SYSTEM; SKIN; YOUNG ADULT;

EID: 84887595505     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12171     Document Type: Review

References (29)

1. Niihori T, Aoki Y, Narumi Y, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 2006; 38: 294-296.
2. Rodriguez-Viciana P, Tetsu O, Tidyman WE, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 2006; 31: 1287-1290.
3. Aoki Y, Niihori T, Kawame H, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 2005; 37: 1038-1040.
4. Gripp KW, Lin AE, Stabley DL, et al. HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation. Am J Med Genet A 2006; 140: 1-7.
5. Kerr B, Delrue MA, Sigaudy S, et al. Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases. J Med Genet 2006; 43: 401-405.
6. Lin AE, Grossfeld PD, Hamilton RM, et al. Further delineation of cardiac abnormalities in Costello syndrome. Am J Med Genet 2002; 111: 115-129.
7. Delrue MA, Chateil JF, Arveiler B, et al. Costello syndrome and neurological abnormalities. Am J Med Genet A 2003; 123: 301-305.
8. Galera C, Delrue MA, Goizet C, et al. Behavioral and temperamental features of children with Costello syndrome. Am J Med Genet A 2006; 140: 968-974.
9. Gripp KW,. Tumor predisposition in Costello syndrome. Am J Med Genet C 2005; 137: 72-77.
10. Nguyen V, Buka RL, Roberts BJ, et al. Cutaneous manifestations of Costello syndrome. Int J Dermatol 2007; 46: 72-76.
11. Weiss G, Confino Y, Shemer A, et al. Cutaneous manifestations in the cardiofaciocutaneous syndrome, a variant of the classical Noonan syndrome. Report of a case and review of the literature. J Eur Acad Dermatol Venereol 2004; 18: 324-327.
12. Siegel DH, McKenzie J, Frieden IJ, et al. Dermatologic findings in 61 mutation-positive individuals with cardio-facio-cutaneous syndrome. Br J Dermatol 2011; 164: 521-529.
13. Siegel DH, Mann JA, Krol AL, et al. Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development. Br J Dermatol 2012; 166: 601-607.
14. Costello JM,. A new syndrome: mental subnormality and nasal papillomata. Aust Paediatr J 1977; 13: 114-118.
15. Costello JM,. A new syndrome. NZ Med J 1971; 74: 397.
16. Hennekam RCM,. Costello syndrome: an overview. Am J Med Genet C 2003; 117: 42-48.
17. Reynolds JF, Neri G, Herrmann JP, et al. New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement-the CFC syndrome. Am J Med Genet 1986; 25: 413-427.
18. Hinek A, Smith AC, Cutiongco EM, et al. Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. Am J Hum Genet 2000; 66: 859-872.
19. Tatano Y, Takahashi T, Tsuji D, et al. Significant decrease in tropoelastin gene expression in fibroblasts from a Japanese Costello syndrome patient with impaired elastogenesis and enhanced proliferation. J Biochem 2006; 140: 193-200.
20. Sarkozy A, Carta C, Moretti S, et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 2009; 30: 695-702.
21. Groesser L, Herschberger E, Ruetten A, et al. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet 2012; 44: 783-787.
22. Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 2013; 133: 2229-2236.
23. Zampino G, Pantaleoni F, Carta C, et al. Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome. Hum Mutat 2007; 28: 265-272.
24. Allanson JE, Annerén G, Aoki Y, et al. Cardio-facio-cutaneous syndrome: does genotype predict phenotype? Am J Med Genet C Semin Med Genet 2011; 157: 129-135.
25. Schulz AL, Albrecht B, Arici C, et al. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome. Clin Genet 2008; 73: 62-70.
26. Fragale A, Tartaglia M, Wu J, et al. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum Mutat 2004; 23: 267-277.
27. Laud K, Kannengiesser C, Avril MF, et al. BRAF as a melanoma susceptibility candidate gene? Cancer Res 2003; 63: 3061-3065.
28. Gill M, Celebi JT,. B-RAF and melanocytic neoplasia. J Am Acad Dermatol 2005; 53: 108-114.
29. Hemesath TJ, Price ER, Takemoto C, et al. MAP kinase links the transcription factor microphthalmia to c-Kit signalling in melanocytes. Nature 1998; 391: 298-301.